Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Fatty Acids and Conjugates [FA01]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA07100007 methyl-2R-hydroxy-goshuyic acid methyl 2R-hydroxy-5Z,8Z-tetradecadienoate SFE 15:2;O C15H26O3 254.188195
LMFA07100007 methyl-2R-hydroxy-goshuyic acid methyl 2R-hydroxy-5Z,8Z-tetradecadienoate SFE 15:2;O C15H26O3 254.188195
LMFA01140109 Tripmycin A 13-(2-methylphenyl)-12E-tridecenoic acid FA 20:5 C20H30O2 302.224581
LMFA01140110 5-(2-Methylphenyl)-4-pentenoic acid FA 12:5 C12H14O2 190.099380
LMFA03010151 PGE2-EA N-(11R,15S-dihydroxy-9-oxo-5Z,13E-prostadienoyl)-ethanolamine NAE 20:4;O3 C22H37NO5 395.267174
LMFA03010151 PGE2-EA N-(11R,15S-dihydroxy-9-oxo-5Z,13E-prostadienoyl)-ethanolamine NAE 20:4;O3 C22H37NO5 395.267174
LMFA03010151 PGE2-EA N-(11R,15S-dihydroxy-9-oxo-5Z,13E-prostadienoyl)-ethanolamine NAE 20:4;O3 C22H37NO5 395.267174
LMFA03010075 PGF2alpha-EA N-(9S,11R,15S-trihydroxy-5Z,13E-prostadienoyl)-ethanolamine NAE 20:3;O3 C22H39NO5 397.282824
LMFA03010075 PGF2alpha-EA N-(9S,11R,15S-trihydroxy-5Z,13E-prostadienoyl)-ethanolamine NAE 20:3;O3 C22H39NO5 397.282824
LMFA03010152 PGD2-EA N-(9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoyl)-ethanolamine NAE 20:4;O3 C22H37NO5 395.267174
LMFA03010152 PGD2-EA N-(9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoyl)-ethanolamine NAE 20:4;O3 C22H37NO5 395.267174
LMFA03010152 PGD2-EA N-(9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoyl)-ethanolamine NAE 20:4;O3 C22H37NO5 395.267174
LMFA01050603 20-HEPE 20-hydroxy-(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoic acid FA 20:5;O C20H30O3 318.219496
LMFA01050604 22-HDHA 22-hydroxy-4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid FA 22:6;O C22H32O3 344.235146
LMFA07070120 3S,7Z-hydroxytetradecenoylcarnitine 3-{[(7Z)-3-hydroxytetradec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 14:1;O C21H39NO5 385.282824
LMFA07070120 3S,7Z-hydroxytetradecenoylcarnitine 3-{[(7Z)-3-hydroxytetradec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 14:1;O C21H39NO5 385.282824
LMFA07070121 3S,5Z-hydroxydodecenoylcarnitine 3S-{[(5Z)-3-hydroxydodec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 12:1;O C19H35NO5 357.251524
LMFA07070121 3S,5Z-hydroxydodecenoylcarnitine 3S-{[(5Z)-3-hydroxydodec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 12:1;O C19H35NO5 357.251524
LMFA07070122 2E,9Z-Hexadecadienoylcarnitine 3-[(2E,9Z)-hexadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 16:2 C23H41NO4 395.303559
LMFA07070122 2E,9Z-Hexadecadienoylcarnitine 3-[(2E,9Z)-hexadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 16:2 C23H41NO4 395.303559
LMFA07070123 2E,7Z-tetradecadienoylcarnitine 3-[(2E,7Z)-tetradeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 14:2 C21H37NO4 367.272259
LMFA07070123 2E,7Z-tetradecadienoylcarnitine 3-[(2E,7Z)-tetradeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 14:2 C21H37NO4 367.272259
LMFA07070124 2E,5Z-dodecadienoylcarnitine 3-[(2E,5Z)-dodeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 12:2 C19H33NO4 339.240959
LMFA07070124 2E,5Z-dodecadienoylcarnitine 3-[(2E,5Z)-dodeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 12:2 C19H33NO4 339.240959
LMFA07070125 2E,9Z-Octadecadienoylcarnitine 3-[(2E,9Z)-octadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 18:2 C25H45NO4 423.334859
LMFA07070125 2E,9Z-Octadecadienoylcarnitine 3-[(2E,9Z)-octadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 18:2 C25H45NO4 423.334859
LMFA07070126 7Z-Hexadecenoylcarnitine 3-[(7Z)-hexadeca-7-enoyloxy]-4-(trimethylazaniumyl)butanoate CAR 16:1 C23H43NO4 397.319209
LMFA07070126 7Z-Hexadecenoylcarnitine 3-[(7Z)-hexadeca-7-enoyloxy]-4-(trimethylazaniumyl)butanoate CAR 16:1 C23H43NO4 397.319209
LMFA07070127 2E,7Z-Hexadecadienoylcarnitine 3-[(2E,7Z)-hexadeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 16:2 C23H41NO4 395.303559
LMFA07070127 2E,7Z-Hexadecadienoylcarnitine 3-[(2E,7Z)-hexadeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 16:2 C23H41NO4 395.303559
LMFA07070128 (7Z)-3S-hydroxyhexadecenoylcarnitine 3S-{[(7Z)-3-hydroxyhexadec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 16:1;O C23H43NO5 413.314124
LMFA07070128 (7Z)-3S-hydroxyhexadecenoylcarnitine 3S-{[(7Z)-3-hydroxyhexadec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 16:1;O C23H43NO5 413.314124
LMFA07070129 (5Z)-3S-hydroxytetradecenoylcarnitine 3S-{[(5Z)-3-hydroxytetradec-5-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 14:1;O C21H39NO5 385.282824
LMFA07070129 (5Z)-3S-hydroxytetradecenoylcarnitine 3S-{[(5Z)-3-hydroxytetradec-5-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 14:1;O C21H39NO5 385.282824
LMFA07070130 2E,5Z-tetradecadienoylcarnitine 3-[(2E,5Z)-tetradeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 14:2 C21H37NO4 367.272259
LMFA07070130 2E,5Z-tetradecadienoylcarnitine 3-[(2E,5Z)-tetradeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 14:2 C21H37NO4 367.272259
LMFA07070134 2E,decenoylcarnitine 3-[(2E-decenoyloxy]-4-(trimethylazaniumyl)butanoate CAR 10:1 C17H31NO4 313.225309
LMFA07070134 2E,decenoylcarnitine 3-[(2E-decenoyloxy]-4-(trimethylazaniumyl)butanoate CAR 10:1 C17H31NO4 313.225309
LMFA07070133 3S-hydroxyoctanoylcarnitine 3S-{[-3-hydroxyoctanoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 8:0;O C15H29NO5 303.204574
LMFA07070133 3S-hydroxyoctanoylcarnitine 3S-{[-3-hydroxyoctanoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 8:0;O C15H29NO5 303.204574
LMFA07070132 3S-hydroxydecanoylcarnitine 3S-{[-3-hydroxydecanoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 10:0;O C17H33NO5 331.235874
LMFA07070132 3S-hydroxydecanoylcarnitine 3S-{[-3-hydroxydecanoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 10:0;O C17H33NO5 331.235874
LMFA07070131 3S-hydroxyhexadecanoylcarnitine 3S-{[-3-hydroxyhexadecanoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 16:0;O C23H45NO5 415.329774
LMFA07070131 3S-hydroxyhexadecanoylcarnitine 3S-{[-3-hydroxyhexadecanoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 16:0;O C23H45NO5 415.329774
LMFA02000412 13S-HOME(9Z) 13S-hydroxy-9Z-octadecenoic acid FA 18:1;O C18H34O3 298.250796
LMFA02000412 13S-HOME(9Z) 13S-hydroxy-9Z-octadecenoic acid FA 18:1;O C18H34O3 298.250796
LMFA02000413 10,13-Dihydroxystearic acid 10,13-Dihydroxyoctadecanoic acid FA 18:0;O2 C18H36O4 316.261361
LMFA03050032 11,12,15-THETA 11,12,15-trihydroxy-5Z,8Z,13E-eicosatrienoic acid FA 20:3;O3 C20H34O5 354.240626
LMFA03050032 11,12,15-THETA 11,12,15-trihydroxy-5Z,8Z,13E-eicosatrienoic acid FA 20:3;O3 C20H34O5 354.240626
LMFA02030075 Callicarboric acid A Methyl (1R,2R)-4-oxo-5-(2-oxo-3E-pentenyl)-2-cyclopentene-1-octanoate FA 19:5;O2 C19H28O4 320.198761